Tag Archive: Diagnostic and Research Growth Center

Mar 21 2019

Digging Deep Into Decisions to Treat Short Stature With Human Growth Hormone

By Nancy McCann

Tall people are self-confident, successful, and have the world at their feet, according to our society’s biases and assumptions. This perception tends to elevate the pressure for parents, children, and clinicians to try human growth hormone (hGH) for treating idiopathic short stature (ISS) — children with severe short stature without an identifiable cause. But how short is severe enough to warrant hGH treatment, which can involve years of daily injections and exposure to potential side effects, at a cost of about $30,000 per patient per year?

Read the rest of this entry >>